1. Spain Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Faes Farma, S.A.

Faes Farma, S.A.

FAE.MC
Faes Farma, S.A.ES flagMadrid Stock Exchange
4.59
EUR
+0.03
- -
1.43BMarket Cap

Total Valuation

Faes Farma, S.A. carries a market capitalization of 1.43B, placing it among publicly traded companies globally. Its enterprise value stands at 973.13M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.43B
Enterprise Value973.13M

Share Statistics

Faes Farma, S.A. currently has 314.02M shares outstanding.

Shares Outstanding314.02M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Faes Farma, S.A. trades at a trailing price-to-earnings ratio of 11.27. The price-to-sales ratio is 2.28, and the price-to-book ratio stands at 6.46.

PE Ratio11.27
PS Ratio2.28
PB Ratio6.46
P/TBV Ratio2.18
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

The EV/Sales ratio of 2.19 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.48 provides insight into valuation relative to core operating earnings.

EV / Sales2.19
EV / EBITDA9.48
EV / EBIT9.48
EV / FCFN/A

Financial Position

Faes Farma, S.A. maintains a current ratio of 3.67, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities.

Current Ratio3.67
Quick Ratio0.57
Debt / Equity1.23
Debt / EBITDA0.08
Interest CoverageN/A

Financial Efficiency

Faes Farma, S.A. posts a return on equity of 59.91 and a return on invested capital of 14.47.

Return on Equity (ROE)59.91
Return on Assets (ROA)12.50
Return on Invested Capital (ROIC)14.47
Return on Capital Employed (ROCE)57.03
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.29

Taxes

Over the trailing twelve months, Faes Farma, S.A. has paid 11.99M in income taxes, reflecting an effective tax rate of 11.82.

Income Tax11.99M
Effective Tax Rate11.82

Stock Price Statistics

Faes Farma, S.A.'s stock has gained approximately 2.45536% over the past 52 weeks. The 50-day moving average sits at 4.65, while the 200-day moving average is 4.75.

Beta (5Y)N/A
52-Week Price Change2.45536%
50-Day Moving Average4.65
200-Day Moving Average4.75
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Faes Farma, S.A. generated 443.96M in revenue and converted that into 89.64M in net income, yielding earnings per share of 0.28. EBITDA reached 102.65M, while operating income came in at 102.65M.

Revenue443.96M
Gross Profit289.72M
Operating Income102.65M
Pretax Income101.42M
Net Income89.64M
EBITDA102.65M
EBIT102.65M
Earnings Per Share (EPS)0.28

Balance Sheet

Faes Farma, S.A. holds 46.52M in cash and equivalents against 7.97M in total debt, resulting in a net debt position of -32.83M. Total book value stands at 156.34M, with working capital of 217.45M providing operational flexibility.

Cash & Cash Equivalents46.52M
Total Debt7.97M
Net Debt-32.83M
Equity (Book Value)156.34M
Book Value Per Share0.49
Working Capital217.45M

Margins

Faes Farma, S.A. operates with a gross margin of 65.26, reflecting its pricing power and cost economics. The operating margin of 23.12 and net profit margin of 20.19 provide insight into operational efficiency.

Gross Margin65.26
Operating Margin23.12
Pretax Margin22.84
Profit Margin20.19
EBITDA Margin23.12

Stock Splits

Faes Farma, S.A.'s most recent stock split took place on April 12, 2023 with a 26:27 split ratio.

Last Split Date4/12/2023
Split Ratio26:27

Scores

Faes Farma, S.A. posts an Altman Z-Score of 7.60, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score7.60